Researchers, Regulators, Industry, Consumer Advocates Gather to Discuss Critical Issues Facing the Pharmaceutical Industry

ARLINGTON, Va.- Unexpected liver damage caused by a new treatment for diabetes, life-threatening side-effects from weight loss drugs, disfiguring skin problems seen with a recently approved AIDS treatment- what do these events have in common? In each case, the serious adverse effects of a newly approved treatment only came to light after the drugs entered the marketplace. And in each case, the current clinical trial and drug approval system was put under scrutiny.

Unexpected adverse reactions to recently approved prescription and over the counter drugs, along with dangerous interactions among otherwise safe drugs highlight some of the issues now facing the consortium of academic researchers, regulatory officials and pharmaceutical industry representatives who together make up the world of new drug development.

Members of the media will have an unprecedented opportunity to hear and interview leading authorities from all of these sectors as they gather to discuss these and other issues at the annual meeting of the American Academy of Pharmaceutical Physicians.

"While there may be increased pressures to get new drugs to patients faster, these must be balanced with the need to perform ethical and safe clinical studies. This year's AAPP conference brings together an excellent roster of true experts from all side of the drug development world for frank discussion of current and future issues in drug development, a crucial but often overlooked field of medicine, said David Shapiro, MD, Vice-President and Trustee, American Academy of Pharmaceutical Physicians.

Some of the leading issues that will be discussed include:

    Pediatrics: In light of the new FDA requirements for pediatric studies, how can the safety and efficacy of drugs intended for pediatric patients be evaluated in clinical trials without putting children at risk?

    AIDS: Has pressure on the FDA to 'fast track' new AIDS treatments put patients at risks of adverse reactions

Contact: Linda Packard
American Academy of Pharmaceutical Physicians

Page: 1 2

Related biology news :

1. Worm Wizardry: Worlds Most Heat-Tolerant Creature Suggests Enzymes For Drugs OrIndustry, UD Prof Says
2. Consumer education and development of bio-sensitive alternatives can revive the plastics industry
3. Consumerism, e-commerce and biotechnology to cause changes in health system over next decade, says PricewaterhouseCoopers study
4. Consumers, health experts desire benefits of biotech foods and concur with current FDA labeling policy
5. Emu Meat Not A Popular Choice Among Consumers, Study Shows
6. Formaldehyde Emissions From Consumer Products
7. Consumer-Oriented Environmental Policy Unsuccessful
8. IFT Report Describes Challenges Of Food Industry Stepping Up To The P(a)lates Of Consumers
9. Early Tests Indicate Motor Skills Unharmed In Consumers Of Tainted Fish
10. Worlds Largest Gathering Of Plant Scientists To Meet In St.Louis, August 1-7, 1999
11. "Health Of Hanford" Conference Gathers Diverse Audience To Review And Discuss Health Issues

Post Your Comments:

(Date:1/4/2019)... ... January 03, 2019 , ... Over the ... into their drug discovery research workflows with biology ranging from single cell-type spheroids ... of in vitro studies, they create several challenges that need to be overcome ...
(Date:12/27/2018)... FRANCISCO (PRWEB) , ... December 27, 2018 , ... ... annual Microbiome Conference at JPM as part of the JP Morgan 37th Annual ... innovative scientists and physicians, and members of the investment community. , Since ...
(Date:12/20/2018)... ... December 20, 2018 , ... Human Factors and product ... a new usability/observation room. This addition will help meet the increased industry demand ... delivery devices/combination products are safe and easy to use when released to the ...
Breaking Biology News(10 mins):
(Date:1/10/2019)... Fla. (PRWEB) , ... January ... ... Geometrical Implant Co, (SAGICO), an innovative spinal implant company, announced today that ... in San Francisco, California. The annual J.P. Morgan Healthcare Conference is ...
(Date:1/7/2019)... SEONGNAM, South Korea (PRWEB) , ... January 07, ... ... has completed Phase 1 clinical trials of its Parkinson's Disease drug candidate, code-named ... disease-modifying treatment of Parkinson's Disease. The trial took place in South Korea. ...
(Date:1/4/2019)... ... January 03, 2019 , ... Calidi Biotherapeutics, Inc., ... today announced the founding of a scientific and medical advisory board (SMAB). The ... leaders in the Immuno-Oncology field. The founding members of Calidi Biotherapeutics SMAB include ...
(Date:12/18/2018)... ... December 17, 2018 , ... ABCT ... emerging biosciences ventures invited to participate in the annual program. Twelve ventures will ... plans and a professional network. All startups receive an entrepreneur coach, access to ...
Breaking Biology Technology:
Cached News: